VA's Roadblock to Progress: Latest Updates on Cannabis and Psychedelics Hung Up to Dry and Put on Shelf in the United States

The latest developments in the cannabis and psychedelics world have been making headlines, shedding light on the ongoing challenges and opportunities surrounding these substances. From research limitations to state legalization efforts and political advocacy, here's an overview of the recent noteworthy events:

Department of Veterans Affairs Blocks Medical Marijuana Recommendations:
The Department of Veterans Affairs issued an updated directive, clarifying that VA doctors will continue to be blocked from issuing medical marijuana recommendations to military veteran patients. Despite bipartisan efforts to change this policy, the directive remains in effect under the Biden administration, disappointing many advocates.

Senate Committee Report Highlights Research Roadblocks:
The Senate Appropriations Committee issued a report emphasizing the obstruction of marijuana and psychedelics research due to their Schedule I status. The report specifically highlighted the inability of scientists to study cannabis products from dispensaries, hindering scientific progress in understanding the potential benefits and risks of these substances.

Florida Attorney General Opposes Legalization Measure:
Florida Attorney General Ashley Moody filed a brief before the state Supreme Court, arguing against a potential legalization measure by Trulieve, a major player in the marijuana market. The brief seemingly undermines the intelligence of voters, insinuating that they may not fully grasp the implications of the measure.

Ohio Activists Submit Signatures for Marijuana Legalization:
Ohio activists submitted a final batch of signatures to put a marijuana legalization initiative on the November ballot after falling short in a prior submission. The move signals a strong push for legalizing cannabis in the state.

Colorado Governor Praises Legalization:
Colorado Governor Jared Polis lauded the state's experience with marijuana and psychedelics legalization, calling it a "very good" move. He cited the economic benefits, job creation, tax revenue, and improved safety associated with the regulated cannabis market.

Chairman of Alabama Medical Cannabis Commission Resigns:
The chairman of the Alabama Medical Cannabis Commission resigned amid legal challenges to his appointment and other disputes regarding marijuana business licensing decisions. The resignation adds further complexity to the state's efforts to implement a medical cannabis program.

Virginia Cracks Down on Illegal Hemp-Derived Products:
The Virginia Department of Agriculture and Consumer Services is imposing fines on businesses allegedly selling illegal hemp-derived products with excessive THC content or products resembling mainstream snack brands. The enforcement aims to ensure compliance with hemp regulations and protect consumers.

As developments continue to unfold in the cannabis and psychedelics landscape, the industry faces both obstacles and progress. From research limitations to state-level efforts and legal challenges, these events shape the trajectory of marijuana and psychedelics policies in the United States. Stay tuned for more updates as the discussions and debates continue to evolve.